Casandra
Casandra Test Code QD90490Version 1 (DRAFT)
Performing Lab
Neisseria gonorrhoeae, TMA (Alternate Target), Urogenital
Also known as: NG TMA, GC TMA, NG APTIMA®, GC APTIMA®
Clinical Use
Order TestUse
This assay is intended to qualitatively detect Neisseria gonorrhoeae by targeting an alternate nucleic acid region using transcription‑mediated amplification (TMA), for confirming positive NAAT screening results that require an alternative target assay structure.
Special Instructions
Not provided.
Limitations
Not provided.
Test Details
Methodology
Other
Biomarkers
Neisseria gonorrhoeae
MicroorganismTMA detection of alternate target • Other • Binary (Detected / Not Detected)
Result Turnaround Time
Not provided.
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Urine
Volume
2 mL
Minimum Volume
Not provided
Container
Aptima® Urine Collection kit
Collection Instructions
2 mL urine with no preservative transferred into an Aptima® Urine Collection kit
Related Tests
Other tests from different labs that may be relevant
Neisseria gonorrhoeae (TMA)
MPLN
Neisseria gonorrhoeae by Transcription-Mediated Amplification (TMA)
ARUP Laboratories
Chlamydia trachomatis and Neisseria gonorrhoeae (CTNG) by Transcription-Mediated Amplification (TMA) with Reflex to CT/NG Confirmation
ARUP Laboratories
Chlamydia trachomatis/Neisseria gonorrhoeae (TMA)
MPLN
Chlamydia/Gonococcus, NAA With Confirmation
Labcorp
Chlamydia trachomatis and Neisseria gonorrhoeae by Transcription-Mediated Amplification (TMA)
ARUP Laboratories
Neisseria gonorrhoeae, NAA
Labcorp
Neisseria gonorrhoeae, Miscellaneous Sites, Nucleic Acid Amplification, Varies
Mayo Clinic Lab
Chlamydia/Gonococcus/Mycoplasma genitalium, NAA, Urine
Labcorp
Neisseria gonorrhoeae, Nucleic Acid Amplification, Varies
Mayo Clinic Lab